{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:22:03Z","timestamp":1794212523573,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1164837"],"award-info":[{"award-number":["OPP1164837"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["324730-165956"],"award-info":[{"award-number":["324730-165956"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["324730_192449"],"award-info":[{"award-number":["324730_192449"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["326000-121314\/1"],"award-info":[{"award-number":["326000-121314\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["853989"],"award-info":[{"award-number":["853989"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Macozinone (MCZ, PBTZ169) is a potent clinical-stage benzothiazinone antitubercular agent that covalently inhibits the essential mycobacterial flavoenzyme DprE1. In some mammals, MCZ undergoes reductive dearomatization to H\n                    <jats:sub>2<\/jats:sub>\n                    MCZ, a Hydride Meisenheimer Complex, identified as the major circulating metabolite in humans. We demonstrate for the first time that the NADPH-dependent human prostaglandin reductases PTGR1 and PTGR2 catalyze MCZ dearomatization into H\n                    <jats:sub>2<\/jats:sub>\n                    MCZ, resulting in loss of antimycobacterial activity. This reaction represents a heretofore undescribed host-mediated metabolic inactivation pathway for a therapeutic agent. Although H\n                    <jats:sub>2<\/jats:sub>\n                    MCZ may constitute a transient reactive intermediate, ex vivo and cellular data indicate that it does not contribute to antimycobacterial activity in vivo. Pharmacological inhibition of PTGR1 and PTGR2 using diclofenac, indomethacin, dicumarol, or the selective inhibitor PTGR2-IN-1 suppresses H\n                    <jats:sub>2<\/jats:sub>\n                    MCZ formation and partially restores MCZ antimycobacterial activity in vitro. Together, these findings uncover a previously unrecognized noncanonical enzymatic mechanism of drug metabolism involving dearomatization in humans. Targeting prostaglandin reductases may represent a strategy to enhance benzothiazinone exposure and efficacy.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00526-1","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:17:06Z","timestamp":1791382626000},"page":"4413-4432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human prostaglandin reductases dearomatize and inactivate benzothiazinone antitubercular drugs"],"prefix":"10.1038","volume":"18","author":[{"given":"Myriam","family":"Briki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1709-5468","authenticated-orcid":false,"given":"Caroline A","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Desfontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Vocat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onya","family":"Opota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Abou-Zite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Corpataux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Cena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Guinchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Versace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarande","family":"Murisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-4837","authenticated-orcid":false,"given":"Thomas","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilyne","family":"Blattes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Bardinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thoueille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3745-7648","authenticated-orcid":false,"given":"Vladimir","family":"Wsol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Lastovickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haithem","family":"Chtioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Rothuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-3167","authenticated-orcid":false,"given":"Aimable","family":"Nahimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-9764","authenticated-orcid":false,"given":"Laurent R","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-8137","authenticated-orcid":false,"given":"Neeraj","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9anne","family":"Lupien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel A","family":"Duchosal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Guery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois R","family":"Girardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Riabova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0639-5536","authenticated-orcid":false,"given":"Thierry","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart T","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-1325","authenticated-orcid":false,"given":"Laurent A","family":"Decosterd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"526_CR1","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1021\/bi0600087","volume":"45","author":"G Asher","year":"2006","unstructured":"Asher G, Dym O, Tsvetkov P, Adler J, Shaul Y (2006) The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 45:6372\u20136378","journal-title":"Biochemistry"},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/jmbi.2001.4779","volume":"310","author":"TM Barna","year":"2001","unstructured":"Barna TM, Khan H, Bruce NC, Barsukov I, Scrutton NS, Moody PC (2001) Crystal structure of pentaerythritol tetranitrate reductase: \u201cflipped\u201d binding geometries for steroid substrates in different redox states of the enzyme. J Mol Biol 310:433\u2013447","journal-title":"J Mol Biol"},{"key":"526_CR3","first-page":"887","volume":"33","author":"P Bico","year":"1994","unstructured":"Bico P, Chen CY, Jones M, Erhardt J, Dirr H (1994) Class pi glutathione S-transferase: Meisenheimer complex formation. Biochem Mol Biol Int 33:887\u2013892","journal-title":"Biochem Mol Biol Int"},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0065-230X(08)60848-9","volume":"29","author":"LF Chasseaud","year":"1979","unstructured":"Chasseaud LF (1979) The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 29:175\u2013274","journal-title":"Adv Cancer Res"},{"key":"526_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0006-2952(88)90727-7","volume":"37","author":"AG Clark","year":"1988","unstructured":"Clark AG, Sinclair M (1988) The Meisenheimer complex of glutathione and trinitrobenzene. A potent inhibitor of the glutathione S-transferase from Galleria mellonella. Biochem Pharm 37:259\u2013263","journal-title":"Biochem Pharm"},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1006\/bbrc.2001.5841","volume":"288","author":"CB Clish","year":"2001","unstructured":"Clish CB, Sun YP, Serhan CN (2001) Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase\/LTB(4) dehydrogenase. Biochem Biophys Res Commun 288:868\u2013874","journal-title":"Biochem Biophys Res Commun"},{"key":"526_CR7","doi-asserted-by":"publisher","first-page":"123555","DOI":"10.1016\/j.jchromb.2022.123555","volume":"1215","author":"V Desfontaine","year":"2023","unstructured":"Desfontaine V, Guinchard S, Marques S, Vocat A, Moulfi F, Versace F, Huser-Pitteloud J, Ivanyuk A, Bardinet C, Makarov V et al (2023) Optimized LC-MS\/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer complex and other metabolites, in human plasma and urine. J Chromatogr B Anal Technol Biomed Life Sci 1215:123555","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/bjc.1989.314","volume":"60","author":"SJ Duthie","year":"1989","unstructured":"Duthie SJ, Grant MH (1989) The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells. Br J Cancer 60:566\u2013571","journal-title":"Br J Cancer"},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"25284","DOI":"10.1074\/jbc.M414645200","volume":"280","author":"J Fang","year":"2005","unstructured":"Fang J, Lu J, Holmgren A (2005) Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 280:25284\u201325290","journal-title":"J Biol Chem"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1128\/AEM.64.8.2864-2868.1998","volume":"64","author":"CE French","year":"1998","unstructured":"French CE, Nicklin S, Bruce NC (1998) Aerobic degradation of 2,4,6-trinitrotoluene by Enterobacter cloacae PB2 and by pentaerythritol tetranitrate reductase. Appl Environ Microbiol 64:2864\u20132868","journal-title":"Appl Environ Microbiol"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bcp.2009.07.023","volume":"79","author":"V Gandin","year":"2010","unstructured":"Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F, Bjornstedt M, Bindoli A, Sturaro A, Rella R, Marzano C (2010) Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharm 79:90\u2013101","journal-title":"Biochem Pharm"},{"key":"526_CR12","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1080\/07391102.2020.1738962","volume":"39","author":"P Guller","year":"2021","unstructured":"Guller P, Karaman M, Guller U, Aksoy M, Kufrevioglu OI (2021) A study on the effects of inhibition mechanism of curcumin, quercetin, and resveratrol on human glutathione reductase through in vitro and in silico approaches. J Biomol Struct Dyn 39:1744\u20131753","journal-title":"J Biomol Struct Dyn"},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharm Toxicol 45:51\u201388","journal-title":"Annu Rev Pharm Toxicol"},{"key":"526_CR14","doi-asserted-by":"publisher","first-page":"100952","DOI":"10.1016\/j.lanmic.2024.07.015","volume":"6","author":"N Heinrich","year":"2025","unstructured":"Heinrich N, de Jager V, Dreisbach J, Gross-Demel P, Schultz S, Gerbach S, Kloss F, Dawson R, Narunsky K, Matt L et al (2025) Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b\/2a trial. Lancet Microbe 6:100952","journal-title":"Lancet Microbe"},{"key":"526_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/03602532.2014.910219","volume":"46","author":"M Huang","year":"2014","unstructured":"Huang M, Hu H, Ma L, Zhou Q, Yu L, Zeng S (2014) Carbon-carbon double-bond reductases in nature. Drug Metab Rev 46:362\u2013378","journal-title":"Drug Metab Rev"},{"key":"526_CR16","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.3390\/ijms22084079","volume":"22","author":"A Ismail","year":"2021","unstructured":"Ismail A, Lewis E, Sjodin B, Mannervik B (2021) Characterization of dog glutathione transferase P1-1, an enzyme relevant to veterinary medicine. Int J Mol Sci 22:4079","journal-title":"Int J Mol Sci"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/00498250701767667","volume":"38","author":"K Itoh","year":"2008","unstructured":"Itoh K, Yamamoto K, Adachi M, Kosaka T, Tanaka Y (2008) Leukotriene B4 12-hydroxydehydrogenase\/15-ketoprostaglandin Delta 13-reductase (LTB4 12-HD\/PGR) responsible for the reduction of a double-bond of the alpha,beta-unsaturated ketone of an aryl propionic acid non-steroidal anti-inflammatory agent CS-670. Xenobiotica 38:249\u2013263","journal-title":"Xenobiotica"},{"key":"526_CR18","doi-asserted-by":"publisher","first-page":"116023","DOI":"10.1016\/j.ejmech.2023.116023","volume":"264","author":"M Joch","year":"2024","unstructured":"Joch M, Wojtas KP, Torres-Gomez H, Li Y, Meyer F, Strassburger M, Kerndl V, Dahse HM, Hertweck C, Hoffmann H et al (2024) Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones. Eur J Med Chem 264:116023","journal-title":"Eur J Med Chem"},{"key":"526_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1515\/tjb-2015-0010","volume":"40","author":"S Karakurt","year":"2015","unstructured":"Karakurt S, Sever M, Celebioglu HU, Adal\u0131 O (2015) Alteration of enzyme activities and kinetic properties of GST and NQO1 with naturally occurring phenolic compounds. Turk J Biochem 40:251\u2013257","journal-title":"Turk J Biochem"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s42004-024-01235-x","volume":"7","author":"F Keiff","year":"2024","unstructured":"Keiff F, Bernal FA, Joch M, Jacques Dit Lapierre TJW, Li Y, Liebing P, Dahse HM, Vilotijevic I, Kloss F (2024) Modulation of the Meisenheimer complex metabolism of nitro-benzothiazinones by targeted C-6 substitution. Commun Chem 7:153","journal-title":"Commun Chem"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10532-012-9611-4","volume":"24","author":"IV Khilyas","year":"2013","unstructured":"Khilyas IV, Ziganshin AM, Pannier AJ, Gerlach R (2013) Effect of ferrihydrite on 2,4,6-trinitrotoluene biotransformation by an aerobic yeast. Biodegradation 24:631\u2013644","journal-title":"Biodegradation"},{"key":"526_CR22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/anie.201609737","volume":"56","author":"F Kloss","year":"2017","unstructured":"Kloss F, Krchnak V, Krchnakova A, Schieferdecker S, Dreisbach J, Krone V, Mollmann U, Hoelscher M, Miller MJ (2017) In vivo dearomatization of the potent antituberculosis agent BTZ043 via Meisenheimer complex formation. Angew Chem Int Ed Engl 56:2187\u20132191","journal-title":"Angew Chem Int Ed Engl"},{"key":"526_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/00498258409151438","volume":"14","author":"TD Lindstrom","year":"1984","unstructured":"Lindstrom TD, Whitaker GW (1984) Saturation of an alpha, beta-unsaturated ketone: a novel xenobiotic biotransformation in mammals. Xenobiotica 14:503\u2013508","journal-title":"Xenobiotica"},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1023\/A:1007195130725","volume":"19","author":"JY Liou","year":"2000","unstructured":"Liou JY, Huang TM, Chang GG (2000) Inhibition of octopus glutathione transferase by Meisenheimer complex analog, S-(2,4,6-trinitrophenyl) glutathione. J Protein Chem 19:615\u2013620","journal-title":"J Protein Chem"},{"key":"526_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1039\/D0MD00390E","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Markley L, Miller PA, Franzblau S, Shetye G, Ma R, Savkova K, Mikusova K, Lee BS, Pethe K et al (2021) Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds. RSC Med Chem 12:62\u201372","journal-title":"RSC Med Chem"},{"key":"526_CR26","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1158\/0008-5472.CAN-05-3310","volume":"66","author":"J Lu","year":"2006","unstructured":"Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A (2006) Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 66:4410\u20134418","journal-title":"Cancer Res"},{"key":"526_CR27","doi-asserted-by":"publisher","first-page":"e00840","DOI":"10.1128\/AAC.00840-18","volume":"62","author":"A Lupien","year":"2018","unstructured":"Lupien A, Vocat A, Foo CS, Blattes E, Gillon JY, Makarov V, Cole ST (2018) Optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone macozinone (PBTZ169). Antimicrob Agents Chemother 62:e00840\u201318","journal-title":"Antimicrob Agents Chemother"},{"key":"526_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/emmm.201303575","volume":"6","author":"V Makarov","year":"2014","unstructured":"Makarov V, Lechartier B, Zhang M, Neres J, van der Sar AM, Raadsen SA, Hartkoorn RC, Ryabova OB, Vocat A, Decosterd LA et al (2014) Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol Med 6:372\u2013383","journal-title":"EMBO Mol Med"},{"key":"526_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.1171583","volume":"324","author":"V Makarov","year":"2009","unstructured":"Makarov V, Manina G, Mikusova K, Mollmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP et al (2009) Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324:801\u2013804","journal-title":"Science"},{"key":"526_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cbi.2014.07.005","volume":"220","author":"P Malatkova","year":"2014","unstructured":"Malatkova P, Havlikova L, Wsol V (2014) The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man. Chem Biol Interact 220:241\u2013247","journal-title":"Chem Biol Interact"},{"key":"526_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/03602532.2013.853078","volume":"46","author":"P Malatkova","year":"2014","unstructured":"Malatkova P, Wsol V (2014) Carbonyl reduction pathways in drug metabolism. Drug Metab Rev 46:96\u2013123","journal-title":"Drug Metab Rev"},{"key":"526_CR32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0006-2952(92)90124-2","volume":"44","author":"JB Mays","year":"1992","unstructured":"Mays JB, Benson AM (1992) Inhibition of mouse glutathione transferases and glutathione peroxidase II by dicumarol and other ligands. Biochem Pharm 44:921\u2013925","journal-title":"Biochem Pharm"},{"key":"526_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/jlac.19023230205","volume":"323","author":"J Meisenheimer","year":"1902","unstructured":"Meisenheimer J (1902) Ueber Reactionen aromatischer Nitrok\u00f6rper. Ann Chem Justus Liebigs Ann Chem 323:205\u2013246","journal-title":"Ann Chem Justus Liebigs Ann Chem"},{"key":"526_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cbi.2015.01.021","volume":"234","author":"J Mesa","year":"2015","unstructured":"Mesa J, Alsina C, Oppermann U, Pares X, Farres J, Porte S (2015) Human prostaglandin reductase 1 (PGR1): substrate specificity, inhibitor analysis and site-directed mutagenesis. Chem Biol Interact 234:105\u2013113","journal-title":"Chem Biol Interact"},{"key":"526_CR35","doi-asserted-by":"crossref","unstructured":"Mesa Solis J (2016) Human prostaglandin reductase 1 (PTGR1): Substrate specificity, site-directed mutagenesis and catalytic mechanism. Universitat Aut\u00f2noma de Barcelona http:\/\/hdl.handle.net\/10803\/394081.","DOI":"10.1016\/j.cbi.2015.01.021"},{"key":"526_CR36","doi-asserted-by":"publisher","first-page":"150ra121","DOI":"10.1126\/scitranslmed.3004395","volume":"4","author":"J Neres","year":"2012","unstructured":"Neres J, Pojer F, Molteni E, Chiarelli LR, Dhar N, Boy-Rottger S, Buroni S, Fullam E, Degiacomi G, Lucarelli AP et al (2012) Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci Transl Med 4:150ra121","journal-title":"Sci Transl Med"},{"key":"526_CR37","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.4049\/jimmunol.2200820","volume":"210","author":"Y Ning","year":"2023","unstructured":"Ning Y, Wang W, Jordan PM, Barth SA, Hofstetter RK, Xu J, Zhang X, Cai Y, Menge C, Chen X, Werz O (2023) Mycobacterium tuberculosis-induced prostaglandin J2 and 15-deoxy-prostaglandin J2 inhibit inflammatory signals in human M1 macrophages via a negative feedback loop. J Immunol 210:1564\u20131575","journal-title":"J Immunol"},{"key":"526_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.tiv.2006.01.012","volume":"20","author":"Y Omata","year":"2006","unstructured":"Omata Y, Folan M, Shaw M, Messer RL, Lockwood PE, Hobbs D, Bouillaguet S, Sano H, Lewis JB, Wataha JC (2006) Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Toxicol Vitr 20:882\u2013890","journal-title":"Toxicol Vitr"},{"key":"526_CR39","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1128\/AEM.66.11.4742-4750.2000","volume":"66","author":"JW Pak","year":"2000","unstructured":"Pak JW, Knoke KL, Noguera DR, Fox BG, Chambliss GH (2000) Transformation of 2,4,6-trinitrotoluene by purified xenobiotic reductase B from Pseudomonas fluorescens I-C. Appl Environ Microbiol 66:4742\u20134750","journal-title":"Appl Environ Microbiol"},{"key":"526_CR40","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F (2002) Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46:2720\u20132722","journal-title":"Antimicrob Agents Chemother"},{"key":"526_CR41","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1021\/acs.chemrestox.9b00450","volume":"33","author":"P Pandey","year":"2020","unstructured":"Pandey P, Avula B, Khan IA, Khan SI, Navarro VJ, Doerksen RJ, Chittiboyina AG (2020) Potential modulation of human NAD[P]H-quinone oxidoreductase 1 (NQO1) by EGCG and its metabolites\u2014a systematic computational study. Chem Res Toxicol 33:2749\u20132764","journal-title":"Chem Res Toxicol"},{"key":"526_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cell.2016.12.029","volume":"168","author":"CG Parker","year":"2017","unstructured":"Parker CG, Galmozzi A, Wang Y, Correia BE, Sasaki K, Joslyn CM, Kim AS, Cavallaro CL, Lawrence RM, Johnson SR et al (2017) Ligand and target discovery by fragment-based screening in human. Cells Cell 168:527\u2013541 e529","journal-title":"Cells Cell"},{"key":"526_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0003-9861(88)90060-4","volume":"267","author":"HJ Prochaska","year":"1988","unstructured":"Prochaska HJ (1988) Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor. Arch Biochem Biophys 267:529\u2013538","journal-title":"Arch Biochem Biophys"},{"key":"526_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56146-9","volume":"16","author":"A Rompp","year":"2025","unstructured":"Rompp A, Treu A, Kokesch-Himmelreich J, Marwitz F, Dreisbach J, Aboutara N, Hillemann D, Garrelts M, Converse PJ, Tyagi S et al (2025) The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis. Nat Commun 16:826","journal-title":"Nat Commun"},{"key":"526_CR45","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1074\/jbc.M802683200","volume":"284","author":"T Seefeldt","year":"2009","unstructured":"Seefeldt T, Zhao Y, Chen W, Raza AS, Carlson L, Herman J, Stoebner A, Hanson S, Foll R, Guan X (2009) Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem 284:2729\u20132737","journal-title":"J Biol Chem"},{"key":"526_CR46","doi-asserted-by":"publisher","first-page":"e0217139","DOI":"10.1371\/journal.pone.0217139","volume":"14","author":"D Spaggiari","year":"2019","unstructured":"Spaggiari D, Desfontaine V, Cruchon S, Guinchard S, Vocat A, Blattes E, Pitteloud J, Ciullini L, Bardinet C, Ivanyuk A et al (2019) Development and validation of a multiplex UHPLC-MS\/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma. PLoS ONE 14:e0217139","journal-title":"PLoS ONE"},{"key":"526_CR47","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/jasms.9b00116","volume":"31","author":"A Tierbach","year":"2020","unstructured":"Tierbach A, Groh KJ, Schonenberger R, Schirmer K, Suter MJ (2020) LC-APCI(-)-MS determination of 1-chloro-2,4-dinitrobenzene, a model substrate for glutathione S-transferases. J Am Soc Mass Spectrom 31:467\u2013472","journal-title":"J Am Soc Mass Spectrom"},{"key":"526_CR48","doi-asserted-by":"publisher","first-page":"e67828","DOI":"10.1371\/journal.pone.0067828","volume":"8","author":"DM Tobin","year":"2013","unstructured":"Tobin DM, Roca FJ, Ray JP, Ko DC, Ramakrishnan L (2013) An enzyme that inactivates the inflammatory mediator leukotriene b4 restricts mycobacterial infection. PLoS ONE 8:e67828","journal-title":"PLoS ONE"},{"key":"526_CR49","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1021\/ja211042r","volume":"134","author":"C Trefzer","year":"2012","unstructured":"Trefzer C, Skovierova H, Buroni S, Bobovska A, Nenci S, Molteni E, Pojer F, Pasca MR, Makarov V, Cole ST et al (2012) Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-beta-D-ribofuranose 2\u2019-oxidase DprE1. J Am Chem Soc 134:912\u2013915","journal-title":"J Am Chem Soc"},{"key":"526_CR50","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1073\/pnas.0501828102","volume":"102","author":"P Tsvetkov","year":"2005","unstructured":"Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J (2005) Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci USA 102:5535\u20135540","journal-title":"Proc Natl Acad Sci USA"},{"key":"526_CR51","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1128\/jb.176.3.932-934.1994","volume":"176","author":"C Vorbeck","year":"1994","unstructured":"Vorbeck C, Lenke H, Fischer P, Knackmuss HJ (1994) Identification of a hydride-Meisenheimer complex as a metabolite of 2,4,6-trinitrotoluene by a Mycobacterium strain. J Bacteriol 176:932\u2013934","journal-title":"J Bacteriol"},{"key":"526_CR52","doi-asserted-by":"publisher","first-page":"717730","DOI":"10.3389\/fphar.2021.717730","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Yin G, Zhang W, Song K, Zhang L, Guo Z (2021) Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy. Front Pharm 12:717730","journal-title":"Front Pharm"},{"key":"526_CR53","first-page":"1479","volume":"20","author":"Y Wang","year":"2008","unstructured":"Wang Y, Zhang H, Holmgren A, Tian W, Zhong L (2008) Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Oncol Rep 20:1479\u20131487","journal-title":"Oncol Rep"},{"key":"526_CR54","unstructured":"WHO (2024) WHO Global Tuberculosis Report 2024. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"526_CR55","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.str.2008.09.007","volume":"16","author":"YH Wu","year":"2008","unstructured":"Wu YH, Ko TP, Guo RT, Hu SM, Chuang LM, Wang AH (2008) Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2. Structure 16:1714\u20131723","journal-title":"Structure"},{"key":"526_CR56","doi-asserted-by":"publisher","first-page":"e59882","DOI":"10.1371\/journal.pone.0059882","volume":"8","author":"L Yu","year":"2013","unstructured":"Yu L, Jiang Y, Wang L, Sheng R, Hu Y, Zeng S (2013) Metabolism of BYZX in human liver microsomes and cytosol: identification of the metabolites and metabolic pathways of BYZX. PLoS ONE 8:e59882","journal-title":"PLoS ONE"},{"key":"526_CR57","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1124\/jpet.112.195768","volume":"343","author":"X Yu","year":"2012","unstructured":"Yu X, Erzinger MM, Pietsch KE, Cervoni-Curet FN, Whang J, Niederhuber J, Sturla SJ (2012) Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent. J Pharm Exp Ther 343:426\u2013433","journal-title":"J Pharm Exp Ther"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00526-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:32:32Z","timestamp":1794209552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00526-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":57,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11,9]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00526-1","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. Since the completion of this work, VD, AM, and DS have become employees of DSM-Firmenich, Merck Group, and Debiopharm International SA, respectively. Their current employer had no involvement in this study and has no commercial or scientific interests related to the subject of this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}